Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Ovarian Neoplasms × defactinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1

Interventions

olaparib 4 Bevacizumab 3 niraparib 2 Paclitaxel 2 rucaparib 1 pembrolizumab 1 entrectinib 1 durvalumab 1 defactinib 1 Taxes 1 Saline Solution 1 Pafolacianine 1 Laparotomy 1 Injections 1 Immunoglobulin G 1 Glucose 1 Docetaxel 1 Disulfides 1 Carboplatin 1 CP protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04625270 2025-01-29

RAMP 201

Verastem, Inc.

Phase 2 Active not recruiting

225 enrolled 1 FDA

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡